• Functional MRI signatures of attentional control were examined in older adults • Individuals had varying levels of Alzheimer Disease-related biomarkers • Task manipulations produced robust block and trial level BOLD signal modulations • Elevated tau and ptau were associated with an over-activation of attention networks • Suggests altered attentional control with elevated Alzheimer Disease pathology
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Introduction
Alzheimer disease (AD) is not a static disorder; there is accumulating evidence that pathological processes begin up to twenty years before symptomatic stages (Bateman et al., 2012; Jack et al., 2013) . Elevated amyloid (Aβ) deposition in the brain is linked to a rise in hyperphosphorylated forms of tau in neuropil threads and neurofibrillary tangles (NFTs) (Hardy and Higgins, 1992) . Aggregated tau leads to neuronal dysfunction and death that manifest in vivo as hypometabolism, atrophy, functional abnormalities, and progressive cognitive impairment (Bateman et al., 2012; Jack et al., 2013) . The early detection of structural or functional changes in the absence of significant cognitive impairment provides candidate biomarkers and therapeutic targets.
In prior work in the literature, at-risk populations have been identified using genetic markers, such as the ε4 allele of the apolipoprotein (APOE) gene, or high levels of amyloid deposition as evidenced by PET. The majority of fMRI studies examining such populations have used variations of memory encoding tasks (Bondi et al., 2005; Bookheimer et al., 2000; Dennis et al., 2010; Filbey et al., 2010; Han et al., 2007; Mormino et al., 2012; Trivedi et al., 2006) .
Although failing episodic memory is a hallmark of AD, the disorder is also characterized by attentional impairments (Bäckman et al., 2005; Balota and Faust, 2001; Perry and Hodges, 1999) . Attentional control discriminates healthy individuals from those with dementia (Bäckman et al., 2005; Hutchison et al., 2010) , predicts progression to dementia in a healthy sample , and from mild to more severe cognitive impairment (Albert et al., 2001; Sarazin et al., 2007) . Early memory deficits in AD may in part be due to an inability to properly allocate attention, rather than pure declines of memory subsystems (Balota and Faust, 2001; 
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al., 2010). The putative relationship between attention and memory is well-established in the literature (e.g. Craik and Lockhart, 1972; Jacoby, 1991) .
Cholinesterase inhibitors used to treat early symptoms of AD prevent the breakdown of acetylcholine (Birks, 2006; Kaduszkiewicz et al., 2005) , which is a neurotransmitter heavily implicated in attentional control (Himmelheber et al., 2000; Sahakian et al., 1989; Sarter and Bruno, 1997) . The basal forebrain cholinergic system projects to higher cortical areas including anterior cingulate, frontal, and parietal cortex (Selden et al., 1998) . These three regions have been repeatedly implicated in neuroimaging studies of attention (Corbetta and Shulman, 2002; Coull and Nobre, 1998; Pardo et al., 1991; Wager et al., 2004) . If attentional control is altered in preclinical AD, functional activity in these regions should be sensitive to rising levels of AD pathology.
To better understand the effects of increasing levels of AD pathology in clinically normal populations, we used two well-studied task-evoked fMRI paradigms (Animacy Judgments and Stroop) to examine cognitively normal adults with varying levels of pathology. Sustained attention was manipulated through the alteration between short rest blocks and longer task
blocks. An event-related design within each block allowed for the examination of trial specific effects. Biomarkers were quantified using 11 [C] Pittsburgh Compound B (PiB) positron emission tomography (PET) and cerebrospinal fluid (CSF) assays. Focusing on attentional control, and including CSF biomarkers, in a task-evoked design provides a novel approach to examining the early influence of AD pathology.
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Study Population
Participants were part of the Adult Children Study at the Knight Alzheimer's Disease
Research Center (ADRC) at Washington University in St. Louis. The Adult Children Study is an ongoing project designed to look at cognitively normal individuals with an elevated risk of developing AD. Participants underwent a clinical assessment, neuropsychological assessment, PiB PET imaging, lumbar puncture (LP), structural MRI, and a functional MRI session.
Participants were right-handed and cognitively normal (Clinical Dementia Rating, CDR=0) (Morris, 1993 ). An initial sample of 92 participants was screened down to 79 by excluding individuals with neurological damage (e.g. stroke, traumatic brain injury n=5), a lag between biomarker and MR acquisition (n=5) more than 3 SD from the initial group mean, or a biomarker values (n=3) more than 3 SD from the initial group mean. After screening for motion and abnormal behavior (see details below) the final cohort consisted of 71 individuals. In this final group the mean lag between functional MRI and biomarker assessment was 39 days (median 0, range 0 to 415) for PET and 473 days (median 161, range 1 to 2227) for LPs. Population demographics are presented in Table 1 .
CSF Samples
CSF (20-30 mL) was collected by LP after overnight fasting (Fagan et al., 2006 
53.5 pg/ml (median 48.5, range 24.8-127.2). For descriptive purposes the percent of the population that would be deemed biomarker positive using previous published cutoffs of less than 459 pg/mL for Aβ 42 , greater than 339 pg/mL for tau, and greater than 67 pg/ML for ptau (Vos et al., 2013 ) is presented in Table 1 . Because the distribution of biomarker values had both high levels of skewness and kurtosis, all analyses of CSF values were log transformed to provide a more normal distribution.
PET Imaging
Methods have been described in detail elsewhere (Su et al., 2013) . Participants underwent a 60-minute dynamic scan with PiB. In each region a tissue mask (grey, white, CSF) was generated based upon the FreeSurfer segmentation (Fischl, 2004) (http://freesurfer.net/). A CSF dilution factor was calculated for each region, and the raw time-activity curve for that region was corrected by this dilution factor before its binding potential was calculated. From the dynamic scan binding potentials were calculated using Logan graphical analysis and a cerebellar reference region. An average across both left and right lateral orbitofrontal, inferior parietal, precuneus, rostral middle frontal, superior frontal, superior temporal, and middle temporal regions derived from FreeSurfer was used to create a mean cortical binding potential (MCBP), with a mean value of .29 (median .13, range .02-1.32). Using a previously published approach using a receiver operator curve (Vos et al., 2013) , amyloid positivity was determined by comparing a large population (n=212) of cognitive normal individuals against a population of mildly demented (CDR=0.5, n=140) with a confirmed diagnosis of DAT. Using this approach positivity was determined as a MCBP greater than .23. For descriptive purposes the percent of the population that would be deemed biomarker positive is presented in Table 1 . As with the CSF biomarkers,
analyses values were log transformed to yield a more normal distribution.
Task Designs
The task design is depicted in Figure 1 . Participants had brief practice with the tasks immediately prior to scanning. In the scanner, participants performed two runs of an animacy judgment task followed by two runs of a Stroop (Stroop, 1935) 
Immediately after scanning, participants completed a surprise memory test outside the scanner. Individuals indicated whether a word had been seen during the Animacy task or whether it was new. They then rated the confidence of their decision from 1 (low) to 5 (high). Participants practiced the judgment procedure using eight words from the practice and eight unseen foils.
They then saw 384 words, half of which were new. Trial presentations were self-paced by the participants. In the scanner the Animacy task was always performed before the Stroop Task to maintain a consistent duration between encoding and test. Based upon abnormal behavior (e.g., more than 50 timeouts or severe problems with vocabulary) five individuals were excluded from the analyses of the Animacy task and two from the Stroop Task.
Scanning Protocol
Data were acquired on a Siemens Trio 3T scanner. T 1 -weighted images were acquired 
Functional Analyses
A population-specific structural atlas was generated using one hundred older adults drawn from a similar but non-overlapping population as those in the study (CDR=0, age range 46-95, mean=71.3, median 71.0, female n=61) who took part in neuroimaging studies at the Knight ADRC. These images underwent a rigid registration to the MNI152 template. The resulting images were averaged together to produce an initial template. Using this template a further nine-step iterative procedure was used, with the resulting image becoming the target template for the next iteration. This process used two rigid registrations, three affine registrations, and four non-linear registrations with FNIRT (Jenkinson et al., 2012) . The final template better represented areas with age related atrophy.
Analyses of the task data were carried out using FEAT, part of FSL (Jenkinson et al., 2012 ) (www.fmrib.ox.ac.uk/fsl). Preprocessing included correcting for field inhomogeneities, motion correction, high-pass temporal filtering with a cutoff of 150 seconds, and spatial smoothing with a 5 mm FWHM Gaussian kernel. EPIs were aligned to a T 1 image using a boundary based registration procedure and aligned into template space using non-linear warping.
Motion parameters were examined for each run. Individuals with an average absolute movement above 1.50 mm, or an average relative movement of .5 mm were excluded from analyses. Using these criteria, a further 8 individuals were excluded from the Animacy analyses and 13 from the The combined first level runs for each subject were entered into a higher-level analysis with participant as a random effect using FLAME (Woolrich et al., 2004) . For each design (e.g., blocked Stroop effects) the group average was modeled while also including age, gender, and years of education as covariates. Expanded analyses targeted the additional influence of each biomarker. These analyses controlled for the interval between biomarker and MRI assessments by including it as a covariate. For all group level analyses the resulting statistics were corrected for multiple comparisons using a cluster thresholding technique (Worsley et al., 1992 ) with a zstatistic threshold of 2.3 and cluster probability threshold of p < 0.05.
Behavioral Results
The behavioral results obtained during both the functional Animacy and Stroop tasks are presented in Table 2 . Values represent marginal means controlling for the effects of age, gender, and education. When performing statistical analyses, reaction time (RT) data were z-transformed within each individual to control for scaling differences in individual response latencies (Faust et al., 1999) . Due to ceiling effects in the Animacy and Stroop tasks, analyses used Fisher transformed accuracy data rather than raw values. When examining the influences of AD M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
Gordon 12 biomarkers, models included the interval between biomarker and MRI assessments as a covariate. Full results of all models examining the effects of biomarkers are presented in Table 3 .
Animacy Task
Accuracy and RT data obtained during the Animacy task were each modeled using a two main analysis additional models were constructed to examine main effects of or interactions with the biomarkers. There were no main effects or interactions with any biomarkers (see Table 3 ).
Memory Effects
Behavioral data from the subsequent memory test are shown in Tables 2 and 3 . On the memory tests participants were faster, more accurate, and more confident for low frequency words compared to high frequency words. Animate objects were more likely to be judged old, whereas inanimate objects were more likely to be judged new, and the response times were consistent with this pattern (see Supplementary Tables 1 and 2 ). For ease of interpretation, all further analyses collapsed across trial types. tau fell slightly below significance. The relationships were such that AD biomarker levels had no influence on RT for previously seen trials, but higher levels of tau/ptau were correlated with longer RTs on trials successfully identified as new and with shorter RTs on trials inaccurately identified as old. Thus, the level of AD pathology was related to the response latencies on lure trials, reflected by slowing of the correct rejections but speeding on the false alarms.
Stroop Task
Accuracy and RT data obtained from the Stroop task were both modeled as repeated measures analyses with three levels (congruent, neutral, and incongruent). There was a significant effect on accuracy (F 2,59 =21.51, p<.0001, = .32) with significant pairwise differences between incongruent and both congruent (t=6.82, p<.0001) and neutral trials (t=5.13, p<.0001), but no difference between congruent and neutral trials (t=2.15, p=.12). There was a
main effect of congruency when examining the reaction time data (F 2,59 =179.57, p<.0001, =
.86 ) with all pairwise comparisons being significant (all p's <.0001). When examining the Stroop Effect (incongruent -congruent trials), there were no significant AD biomarker effects on accuracy or RT that survived the multiple comparisons.
Functional Results
Animacy Task
Block level analyses yielded robust BOLD increases during task performance in visual, motor, and attentional networks, and decreases in the default mode network (DMN) (Figure 2a ).
When contrasting trial types, animate trials had significantly reduced deactivations of the DMN, whereas inanimate trials had greater increases in motor areas (Figure3a). As word frequency increased there was a smaller deactivation of the precuneus. As frequency decreased there were larger increases in activation the left dorsolateral prefrontal cortex (DLPFC) and visual word form area (Figure 3b ). The color scales on the figures were selected to show the dynamic range of the effects and full cluster information for all effects are presented in Supplementary Tables 3-5 .
In addition to the frequency and animacy effects, there was a clear subsequent memory effect (see Paller and Wagner, 2002) . Specifically, compared to forgotten words, highly confident remembered words evoked greater BOLD signal in the anterior cingulate, medial prefrontal cortex, left entorhinal and parahippocampal cortex, left temporal lobe and extensively in the left DLPFC. Forgotten word trials had smaller deactivations in the precuneus and larger increases in the right angular gyrus (Figure 3c ). (Figure 4a-4d ). These regions were activated relative to baseline, and the level of activation increased with rising levels of tau and ptau. There were no significant block level associations with CSF Aβ 42 or MCBP. Although the regions that reached statistical significance varied somewhat by task and biomarker (tau vs. ptau), by using a lower statistical threshold it is possible to see that the spatial patterns are remarkably similar across the four maps (see Figure 4 areas in green). It is possibly that the modulation of the block level effects by levels of tau and ptau were driven by a subset of the cohort. In order to address this issue, we used the areas that reached significance in Figure 4a as a region of interest to display the relationship between log ptau and alterations in the BOLD signal across the cohort ( Figure 5 ). This figure indicates a relatively continuous effect of rising levels of pathology on blood flow.
There was only one interaction between trial level effects and biomarkers. When examining the difference between highly confident remembered trials to those later forgotten, M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
Gordon 16 there was a negative association with tau in bilateral motor areas (Figure 4e ). This indicated that as tau levels increased the differences between highly confident remembered and forgotten trials became more negative in this region. Cluster information for all effects are presented in Supplementary Tables 3-5 .
Discussion
The focus of the current research was to examine the presence of functional changes tied to AD pathology using a design that estimated both block and trial level activity. The combination of block and trial level manipulations allowed the examination of large-scale attentional fluctuations, trial level attentional manipulations, as well as estimation of subsequent memory effects. The trial level manipulations produced results consistent with prior work examining animacy (Grossman et al., 2002) , word frequency (Kronbichler et al., 2004) , subsequent memory (Kim, 2011) , and Stroop effects (Derrfuss et al., 2005) , but these effects were minimally modulated by levels of AD biomarkers. The block level manipulations produced robust patterns of activation and deactivation correlated with large-scale shifts in sustained attention. Importantly, these block-level effects were related to tau and ptau levels in both tasks.
These results occurred in the absence of significant behavioral impairment, as is consistent with prior work examining nondemented individuals with an elevated levels of AD biomarkers or a The tau and ptau modulations were highly co-localized with tissue activated by the task.
On average 75% of the voxels that were significantly modulated by tau or ptau were also M A N U S C R I P T
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Gordon 17 activated by their respective task, while less that .05% of the voxels fell in areas that were deactivated. Further it is not just the extent of this overlap that is noteworthy, but the specific regions that produce this overlap. The greatest effects of the AD biomarkers occurred in the right dorsolateral prefrontal cortex, anterior cingulate, and lateral parietal regions, which have long been associated with executive control, attention, and working memory (Banich et al., 2000; Corbetta and Shulman, 2002; Coull and Nobre, 1998; Kane and Engle, 2002; MacDonald et al., 2000; Milham et al., 2002; Pardo et al., 1991; Wager et al., 2004) . The modulation of these attentional control networks supports theories that early stages of AD are accompanied by alterations in attentional control (Bäckman et al., 2005; Balota and Faust, 2001; Duchek et al., 2013; Hutchison et al., 2010; Perry and Hodges, 1999 ).
The present study indicated that across two tasks, individuals with higher levels of AD injury biomarkers over-activated attentional areas. A diffuse or inefficient mobilization of attentional networks would create poorer representations of attended material that in turn would negatively affect memory performance. Due to the high levels of performance, it is unclear whether the observed overactivations represent successful compensatory mechanisms or detrimental effects that have not yet reached a level to impact performance. As with work on aging (Schneider-Garces et al., 2010), future studies using parametric manipulations of difficulty are needed to disentangle such mechanisms.
When examining the difference between remembered and forgotten trials there was a small effect of tau in motor cortex. The relationship was such that the difference between remembered and forgotten trials in this area increased with rising levels of tau. This may reflect a consequence of strategic differences at the time of the initial animacy judgments, which are later predictive of memory. There was also a significant three-way interaction behaviorally with ptau M A N U S C R I P T
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when examining tests of memory. When faced with unseen words, increasing levels of ptau predicted more rapid incorrect false alarms, but much longer successful correct rejections. This suggests a difficulty overcoming the general sense of familiarity when presented with unseen words.
Prior work in the literature has primarily determined AD risk by the presence of an APOE This study is the first to relate task-evoked functional changes to levels of tau and ptau.
We found that task-evoked alterations in the BOLD signal were most sensitive to tau rather than amyloid pathology in nondemented individuals. This is consistent with prior work indicating that the progression of dementia is not correlated best with amyloid, but rather with synaptic and neuronal loss, which is more tightly coupled with levels of NFTs (Gomez-Isla et al., 1996; Ingelsson et al., 2004; Morris and Price, 2001 ). Whereas most previous fMRI studies of AD using amyloid PET have focused on explicit memory encoding tasks, here we utilized large-scale manipulations of attention. As tau and amyloid pathology have divergent spatial topographies M A N U S C R I P T
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Increased levels of tau and ptau were linked to widespread block level modulations of the BOLD signal, but had minimal interactions with trial level effects. There are two potential interpretations of this pattern. The first is that pathological processes affect gross attentional modulation while sparing focal trial-to-trial allocations of resources. A second interpretation is that detrimental processes are occurring at both levels, but the current design is more sensitive to large-scale shifts compared to subtle differences across trial types.
There are some limitations to the present study. First, this study examined a crosssectional relationship between measures of AD pathology and altered fMRI activity. It may be that the longitudinal trajectories of the pathological markers are more related to alteration in attentional control. Additionally, although the lag between PET and MRI sessions was minimal, a subset of individuals had relatively long lags between CSF collection and the MRI. To address this variability, all statistical models examining biomarkers included the lag between an individual's MRI and biomarker session as a covariate. As an additional test, we split the data presented in Figure 5 into two groups: individuals with a CSF-to-MRI lag less than or greater than two years. In this model, again including age, gender, and education as covariates, the relationship between levels of ptau and BOLD modulation remain highly significant (F 1,59 48.49, p <.00001) and there was no modulation of this relationship by lag group (F 1,59 = 1.02, p=.32) (See Figure 6 ). This indicates that at least within the current lag ranges, there is no systematic change in the CSF biomarker-block level fMRI relationship.
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In the present study we have focused on attentional control systems due to accumulating evidence that attention plays a critical role in early stage AD (see Balota and Ducheck, 2014) .
Indeed, during the current Animacy and Stroop tasks we observed alterations in task-evoked activity related to AD biomarkers even though there was relatively little demand on memory systems. Since there is a critical link between attention and memory processing (Craik and Lockhart, 1972; Jacoby, 1991) , these alterations in block-level sustained attention may ultimately be a predictor of later disruptions of memory processing. Following our cohort longitudinally will provide insight into the utility of using overactivations of attentional control networks to predict subsequent cognitive decline. Finally, studies in the field should consider combining encoding tasks with very little memory demand with memory retrieval tasks to examine the sensitivity of attention and/or memory to AD pathology.
Great strides have been made characterizing early AD abnormalities in vivo using structural and functional magnetic resonance imaging, PET, CSF assays, and cognitive tests (Holtzman et al., 2011) . Efforts are underway to integrate these techniques to develop biomarkers to aid in disease diagnosis, prognosis, and prevention. As CSF assays and PET tau tracers become more widespread, it will be possible to determine if neural measures of tau and amyloid pathology preferentially affect different functional and cognitive systems. Exploring sustained attention may be sensitive to these very early biomarkers of AD.
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